![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/02/2907131/0/en/Ipsen-expands-collaboration-and-license-agreement-for-development-of-Cabometyx-in-advanced-neuroendocrine-tumors-based-on-positive-CABINET-Phase-III-trial.html
https://endpts.com/roche-and-exelixis-detail-rare-success-for-cabometyx-tecentriq-combo-in-prostate-cancer/